-- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action -- August 31, 2025 08:30 ET | Source: Amarin…
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or…
Study shows sustained improvements in heart failure symptoms and function following long-term C-MIC therapy ZUG, Switzerland, July 16, 2025 /PRNewswire/ -- Berlin…